{"id":"W4366831740","doi":"10.1093/rheumatology/kead104.226","title":"P185 Long-term efficacy and safety of upadacitinib in patients with psoriatic arthritis refractory to biologic therapies: 2-year results from the phase 3 SELECT-PsA 2 study","year":2023,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Adverse effect; Discontinuation; Internal medicine; Placebo; Psoriasis; Tolerability; Phases of clinical research; Rheumatoid arthritis; Clinical trial; Gastroenterology; Surgery; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002561125,0.0005214611,0.001135877,0.00022068,0.0003160913,0.0007713969,0.0002605534,0.0005576602,0.001315348],"category_scores_gemma":[0.001559891,0.0002185182,0.001425562,0.0003786179,0.0003203878,0.0004776535,0.0003302676,0.001254865,0.0002905634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003744244,"about_ca_system_score_gemma":0.0007858269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004586888,"about_ca_topic_score_gemma":0.001003217,"domain_scores_codex":[0.9992937,0.0003574579,0.00005902127,0.00007521083,0.0001271003,0.00008760276],"domain_scores_gemma":[0.9985858,0.0003761056,0.0005459611,0.00008672346,0.0001406727,0.0002646982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6083457,0.02132565,0.1175681,0.001646234,0.005987547,0.0005237554,0.0002853523,0.002897563,0.0218264,0.0002068587,0.006327372,0.2130594],"study_design_scores_gemma":[0.2402489,0.3895924,0.3424115,0.0001783866,0.007187438,0.001094655,0.0002162314,0.004471284,0.008041816,0.0003457644,0.006120229,0.00009144752],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943717,0.002840071,0.000353458,0.0001645153,0.00003926465,0.0003577722,0.001091386,0.00002384212,0.0007580625],"genre_scores_gemma":[0.9961919,0.0009112501,0.0004001372,0.0003012947,0.00009535626,0.0003124295,0.001364975,0.00000615703,0.0004165962],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002561125,"threshold_uncertainty_score":0.01354468,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01840985030816601,"score_gpt":0.2841749878347811,"score_spread":0.2657651375266151,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}